Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Boehringer Mannheim clot-busting drug introduced in first market

Jan. 7, 1997

Thrombolytic agent introduced in Germany

Dec. 31, 1996

BMS describes thrombin-activatable plasminogen activator

Dec. 31, 1996

Novel thrombin inhibitors in development at LG Chemical

Dec. 31, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Corvas and Schering-Plough expand antithrombotic collaboration

Dec. 18, 1996

New antiplatelet agents described by Thomae

Dec. 17, 1996

FDA panel recommends approval of BeneFix

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.